Batten's disease; motor neuron degeneration; metabolic profile; metabotype; neuronal ceroid lipofuscinosis; vitamin E NEURONAL CEROID LIPOFUSCINOSES (NCL) are a series of autosomal recessive diseases, which together comprise the most common neurodegenerative disorders of childhood, with an incidence of 1 in 12,500 (30) . The diseases are heterogeneous, based on four subtypes characterized by clinical pathology and age of onset and have been mapped to the gene loci CLN1 to CLN8 (2, 5, 10, 18, 21, 32, 37) .
Despite the different gene loci, the diseases are typified by the accumulation of autofluorescent lipopigments in lysosomes, similar to the pigment lipofuscin, found in normal ageing brains (19, 31) , and ceroid, found in pathological conditions (38) , both formed by peroxidation of polyunsaturated fats. NCL diseases are also characterized by lysosomal abnormalities distinct to the individual forms (27) , including the presence of inclusion bodies and the deposition of proteins such as subunit C of mitochondrial ATP synthase (13, 15, 27) . Free radical generation is thought to take place at these inclusions sites, and as with motor neuron disease [amyotrophic lateral sclerosis (ALS)] and Parkinson's disease, peroxidation preferentially damages neuronal subgroups, producing the characteristic neurological degeneration. Although the complete biochemical processes that cause the NCLs are still to be defined, lipid handling, particularly within lysosomes, appears central to the disorders (10) .
There has been a long-standing interest in the role of antioxidant molecules in diseases of the nervous system, and that failure of antioxidant protection is a common pathogenetic process in many neurodegenerative pathologies, including the NCL diseases. Decreased antioxidant levels have been reported in many neurological disorders, and on the basis of such evidence, antioxidant therapy has been used, in formal clinical trials but also widely as ad hoc dietary supplements by patients. The use of a model system that shows neurodegeneration in the presence of an antioxidant deficit allows the primary and secondary effects of the disease process and antioxidant deficit to be addressed.
The mnd mouse is a model of NCL (Batten's disease variant) (12, 20) , with a mutation linked to the CLN8 gene (29) . The model shows many of the characteristics of NCL, including retinal and neuronal degeneration and autofluorescent lipopigment in lysosomal storage pools (7) . Vance and colleagues (34) have suggested that the transport of fats between the endoplasmic reticulum and mitochondria is impaired in these mice, implicating the involvement of defective mitochondrial-associated membranes (MAMs). In this study, we demonstrate biochemical abnormalities of the brain and blood plasma using high-resolution proton nuclear magnetic resonance ( 1 H-NMR) spectroscopy and biochemical assay to metabolically profile the mnd mouse. By using such metabolic profiles to describe the dynamic phenotype of the mnd mouse during dietary supplementation, this study was able to investigate why, despite dietary supplementation of vitamin E reversing a detected deficiency of the vitamin in the mnd mouse, this did not reverse the pathological changes.
MATERIALS AND METHODS
Animal husbandry and procedures. Mnd and C57B6 control mice were maintained under standard conditions with food and water ad libitum. All procedures conformed to the UK Home Office regulations concerning the use of animals. Animals were kept in a constant environment with a 12:12-h light/dark cycle.
For biochemical assays two sets each of mnd and C57B6 control mice were fed on one of three diets [Special Diet Services (SDS)] after weaning (standard SDS1 is diet 1; SDS diet ϩ 10 times vitamin E concentration is diet 2; and SDS diet ϩ 10 times the concentration of vitamin E, vitamin C, and selenium is diet 3). Animals were killed by rising concentrations of carbon dioxide at 4 or 6 mo of age (n ϭ 6 for each group). Brain tissue was rapidly dissected and frozen in liquid nitrogen, typically within 30 s postmortem. A terminal bleed was taken by cardiac puncture, and serum was separated by centrifugation. For metabolic analysis using 1 H-NMR spectroscopy, two sets of mnd and control mice were fed one of the three diets described above (n ϭ 5 for each group). Animals were killed at 6 mo of age by rising concentrations of carbon dioxide. Half the cerebral cortex was rapidly dissected and frozen using liquid nitrogen within 30 s. These samples were stored at 203 K. Additional samples were also collected from the remaining tissue and stored in 10% formal saline for histological analysis. Sera were collected as above and stored at 233 K.
Histology of brain tissue. Fixed cerebral samples were processed in paraffin wax using standard methods. Sections were cut at 10 m thickness and stained with the Luxol-fast blue, Cresyl violet method to identify inclusion material more clearly.
Analysis of vitamin E and lipid content in brain tissue and blood plasma. Vitamin E content was determined using highperformance liquid chromatography (HPLC) with fluorometric detection using the method described by Buttriss and Diplock (4) . Vitamin E concentrations were expressed in terms of cerebral tissue weight or ml of plasma.
Preparation of cerebral cortex extracts and NMR spectroscopy. Frozen tissue (ϳ100 mg) was pulverized and added to 6% perchloric acid. The supernatant was neutralized with NaOH, lyophilized, and reconstituted in 2 H2O. Solutions were pipetted into 5-mm NMR tubes and analyzed using a spectrometer interfaced to a 14.1-Tesla magnet with a triple axis inverse geometry probe (model DRX 600; Bruker, Kahrlruhe, Germany).
1 H-NMR spectra were acquired using a standard presaturation pulse sequence based on the start of the nuclear Overhauser effect spectroscopy (NOESY) pulse sequence for water suppression (relaxation delay ϭ 2 s, "mixing time" ϭ 150 ms, time domain ϭ 32 k data points, SW ϭ12 ppm, solvent presaturation applied during the relaxation delay and mixing time). After multiplication with an exponential function (equivalent to 0.3 Hz line broadening) and Fourier transformation of the free induction decays from the time into the frequency domain, spectra were processed using XWIN-NMR (Bruker). Spectra were phased and baseline corrected using standard routines. To confirm spectral assignments made using literature values, gradient correlation spectroscopy (COSY), gradient heteronuclear single quantum coherence (HSQC), and two-dimensional J-resolved spectra were acquired using standard pulse programs.
Blood sera samples consisted of 300 l of sera, 500 l of sodium phosphate buffer (pH 7.1) and 100 l of 2 H2O (internal lock) with sodium-3-(trimethyl)-2 H4-proprionate (TSP; final concentration 1 mM) as an internal reference standard (␦ ϭ 0.0 ppm). Blood sera were analyzed by 1 H-NMR spectroscopy (256 acquisitions and 2-s interpulse delay) using a solvent suppressed pulse sequence with a total T2 filter of 80 ms to attenuate broad signals from proteins and lipoproteins. Other acquisition parameters were as described above.
To further investigate cerebral tissue from mnd mice, intact cortical tissue from either mnd or control mice fed diet 1 or 2 (n ϭ 4; ϳ10 mg of tissue with ϳ5 l of 2 H2O acting as a frequency lock) were placed in a zirconium oxide rotors in a high-resolution magic angle spinning (HRMAS) probe, interfaced to the spectrometer described above. Samples were spun at 5,000 Hz at a temperature of 300 K. Initial 1 H-NMR spectra were acquired with 128 scans using the solvent suppressed sequence described above (total experimental time ϳ5 min). A sequential series of spectra were acquired every 30 min to monitor the degradation of N-acetyl-L-aspartate (NAA) to acetate. These changes were then fitted to a monoexponential to estimate the rate of degradation.
Pattern recognition of NMR spectra. For pattern recognition analysis, 1 H-NMR spectra were data reduced (AMIX v.2, Bruker) by subdivision into 0.04 ppm designated regions from ␦ 0.4-4.5. Each spectral region was normalized to the summation of spectral regions for the entire integral region of the spectrum, accounting for dilution or bulk mass differences between samples. Correlation principal components analysis (PCA) was performed using Pirouette v. 2.6 (InfoMetrix, Woodinville, WA) and SIMCA (Umea, Sweden). PCA is an unsupervised method of classification, requiring no training set of data, and hence is ideally suited to matrices with small group sizes, but large number of measurable parameters, correlating the variation detected in a data set to a spatial representation. The first PC generated by this method represents the maximum variation that is correlated, with subsequent PCs representing less variation and chosen to be orthogonal to the first PC.
Mean-centered, Pareto, and autoscaling routines were applied to the spectral data prior to PCA (11) . Mean-centered analysis involved subtraction of the mean of the integral for a designated spectral region and PCA measures variance about this mean. Thus PCs in mean centered data are influenced by regions with the maximum variance about the mean. Autoscaled analysis sets each integral region to unit variance by scaling each region by 1/sk where sk represents the standard deviation of the variable k, following mean centering of the data set. This weights spectra so that features with lower spectral intensity and the high-concentration metabolites contribute equally to the PC analysis. Pareto scaling weights the integral regions to (1/sk) 1/2 and results in an analysis midway between the other routines. Spectral data were reduced from 103 spectral descriptors to a number of PCs (typically less than 5), as determined by the maximization of cumulative total variation in the data that is predicted by those components. Loading plots from the PC analysis were used to identify metabolite (via their resonances) changes between groups. This was cross-validated with spectra both visually and by manual integration of the regions.
Statistical analysis. Data are represented as means Ϯ standard deviation (SD) of the mean. Student's t-test (for two-way comparisons) and ANOVA test of variance with Tukey posttests were performed using Instat (Graphpad). To demonstrate the multiparametric analysis is also capable of identifying metabolite changes that were significantly different according to normal parametric tests, key metabolites were further investigated. For quoted metabolite ratios, integrals were calculated manually using Lorentzian line shapes to fit spectral resonances, and the ratios were compared using standard parametric tests.
RESULTS
Phenotype. Visual and gait disturbances were seen at 6 mo of age in all the mnd mice. No functional or behavioral differences were noted between groups of age-matched mnd mice, regardless of diet. Control mice showed no signs of ill health during the study.
Histology of brain tissue. Histological analysis was used to supplement observed phenotype, with the presence of intraneuronal inclusion material being constantly associated with the mnd phenotype. Neuronal inclusion material was present as eosinophilic masses within the cytoplasm on hematoxylin and eosin staining and stained positively with the Luxol fast blue/ Cresyl violet method (Fig. 1 ). Inclusions were seen in most neuronal groups but were most evident in large neurons, such as pyramidal neurons of the cerebral cortex. No differences were noted in the amount or distribution of inclusion material between mnd mice of the same age on diet 1, 2, or 3. Tissue from control mice had no abnormal histological features in any group.
Vitamin E content of tissues. At 4 mo mnd mice had decreased vitamin E content in brain tissue compared with control animals ( Fig. 2) according to an ANOVA test followed by Tukey posttesting, with this deficit increasing by 6 mo (P Ͻ 0.05 for difference between mnd and control mice fed diet 1 at 4 and 6 mo).
Dietary supplementation of vitamin E increased its content to above control levels in sera for both mice strains, with content rising approximately two-and threefold in control and mnd mice at 6 mo, respectively (P Ͻ 0.05 for increase in vitamin E content in mnd mice on diet 2 compared with diet 1 at 4 and 6 mo). Supplementation of vitamin E in mnd mice increased vitamin E content above that found in control mice on the normal diet for both sera and cerebral tissue, indicating the vitamin E deficiency was reversed.
Serum metabolic profiles. The spectral profiles of sera from mnd mice (Fig. 3, A and B) showed a number of metabolic perturbations compared with control animals and were separated using PC analysis. For a comparison between all mnd mice and control mice, regardless of diet, this separation was represented by PC 1 and PC 2, accounting for 66.3% of the total spectral variation (Fig. 3C) . Lactate, CH 3 CH 2 O lipid moieties and glucose were all decreased in mnd mouse serum whereas CH 2 CH 2 CH 2 lipid moieties were relatively increased (Fig. 3D ). (Note: here and throughout, boldface indicates "resonance observed.") Supplementation of vitamin E to the diet of mnd mice caused a decrease in the resonance intensities of lipid polyunsaturated groups in the sera spectra, especially at ␦ 2.78 associated with CACCH 2 CAC moieties. Manual integration of this peak and expressing it as a ratio with the lactate resonance, at ␦ 1.33 indicated a twofold relative decrease (diet 1 ϭ 0.095 Ϯ 0.017, diet 2 ϭ 0.050 Ϯ 0.005, P Ͻ 0.05; Student's t-test). However, this change was not observed in control animals. In addition to this difference, spectral profiles of mnd mouse blood plasma indicated increased CH 2 CH 2 CH 2 lipid moieties and a general decrease in glucose resonances compared with blood plasma from control animals also fed on diet 2. The relative ratio of the integrals of the glucose resonance at ␦ 3.42 and the CH 2 CH 2 CH 2 lipid moiety at ␦ 1.30 showed a greater than twofold decrease between Fig. 1 . Luxophilic cytoplasmic inclusion bodies in the cerebral cortex of the mnd mouse: Luxol fast blue and Cresyl violet staining; magnification, ϫ100. Arrow shows an inclusion body. No inclusions bodies were found in cerebral tissue of control mice, whereas all cerebral tissue from mnd mice had inclusion bodies, regardless of diet. mouse types (P Ͻ 0.01 for Student's t-test). These differences were also apparent in the two mice groups fed diet supplemented with vitamins E and C and selenium (diet 3).
For all comparisons the metabolic changes caused by gene expression were greater than those caused by diet. Thus the metabolic profiles of sera from mnd mice were metabolically perturbed, and sera glucose concentrations in all three groups of mnd mice were reduced. Vitamin E supplementation reduced the concentration of serum unsaturated fatty acids in mnd mice but failed to correct the other metabolic deficits detected.
Cerebral metabolic profiles. Cerebral cortex tissue extracts (Fig. 4) from mnd mice were readily separated according to PC analysis, following all the preprocessing routines, regardless of diet (Fig. 5A) . To further investigate the biochemical differences present within the cerebral tissue of mnd mice, the individual diet groups were investigated alongside their control siblings. Mnd and control mice were separated in PC analysis along PC 1, representing the maximum variance in the data set ( Fig. 5B; 30 .2% of the variance for Pareto scaled data; P Ͻ 0.05 for difference in PC loading). Examining the contribution plots, this was caused by increased ␤-hydroxybutyrate (␦ 1.22), taurine (␦ 3.26), and glutamate (␦ 2.12, 2.36) and decreased creatine (␦ 3.02), aspartate (␦ 2.88), glutamine (␦ 2.20), and GABA (␦ 1.84) tissue content (Fig. 5E) . Pattern recognition was applied only to the aliphatic region of the spectrum, because of variability in water suppression, but in the spectra from mnd mouse tissue phenylalanine was also present (Fig. 4B) .
Supplementing the diet with extra vitamin E reduced the concentration of phenylalanine dramatically in extracts of mnd brain [relative ratio of phenylalanine (␦ 7. (Fig. 5B) . Again, this separation was caused by decreases in concentration of creatine (␦ 3.02), aspartate (␦ 2.88), and glutamine (␦ 2.20) and an increase in glutamate (␦ 2.36, 2.14), and ␤-hydroxybutyrate (␦ 1.24), as well as an increase in concentration of lactate (␦ 1.33) and NAA (␦ 2.0) (Fig. 5F ). Supplementation of the diet with vitamins E and C as well as selenium (diet 3) produced spectral profiles similar to that observed during simple vitamin E supplementation alone, and animals fed either diet 2 or 3 could not be separated by PCA alone for one particular strain (Fig. 5C ). Thus, despite vitamin E supplementation reversing the cerebral deficit in vitamin E, mnd mice had a metabolic profile distinct from control animals, and this perturbation was larger than the effect associated with diet. The key metabolite changes are summarized in Table 1 .
No common biochemical effect was detected by PCA for both mouse strains attributable to vitamin E supplementation, until the data set was preprocessed using orthogonal signal correction (OSC; 20), indicating that the biochemical abnormalities associated with NCL were far greater than the changes induced by vitamin E supplementation. OSC removes variation not correlated with a Y variable. Following OSC, to separate variation not correlated to vitamin E content within the tissue (removing 67% of the variation in the data set over two PLS components), the spectra from Fig. 2 . Vitamin E content in sera (top) and cerebral cortex (bottom) of the mnd mouse. By means of an ANOVA test of variance, vitamin E content was found to be significantly altered across the three diets, two age groups, and two mouse strains investigated for both sera and cerebral tissue (P Ͻ 0.0001). Selected Tukey posttests were then applied. Data are means Ϯ SD (n ϭ 6). Odd numbers indicate 4-mo-old animals, even numbers are for 6-mo-old animals, for diet 1 (1 and 2), diet 2 (3 and 4), and diet 3 (5 and 6). *P Ͻ 0.05 for Tukey posttest for difference between mnd and control mice at the same age and on the same diet.
# P Ͻ 0.05 for difference between mnd mice on diet 1 and either diet 2 or diet 3 for same age mice.
animals receiving supplemented vitamin E in their diets were separated in PCs 2 and 3 ( Fig. 5e) , with the OSC weighted loadings being affected most by the relative ratios of alanine to creatine and alanine to aspartate (increased during vitamin E supplementation). However, the low goodness of fits (R 2 ) for PCs 2 and 3 indicated that this trend was weak.
In summary, vitamin E supplementation reduced the high concentrations of phenylalanine and ␤-hydroxybutyrate detected in cerebral tissue of mnd mice but did not fully restore the abnormal concentrations of other low-molecular-weight metabolites including glutamate, glutamine, aspartate, and creatine within cerebral tissue from mnd mice.
Intact cerebral cortical tissue. Using high-resolution MAS 1 H-NMR spectroscopy, spectral profiles were obtained of mnd and control mice fed diets 1 and 2. Tissue from mnd mice clearly had increased lipid content, with the CH 2 CH 2 CH 2 resonance being particularly prominent (␦ 1.3 ppm) (Fig. 6A) . Unlike tissue obtained from control animals, tissue from mnd mice also had a visible resonance associated with CHACH lipid moieties at 5.6 ppm. Application of PCA to the intact spectra readily separated tissue from control and mnd mice along PC 1 (P Ͻ 0.005 for difference between strains), and this was largely caused by the CH 2 CH 2 CH 2 lipid resonance, confirming the changes detected visually. Similar lipid deposits were detected in spectra from mnd mice fed diet 2, and PCA failed to separate the mice according to diet for either strain.
While initial spectra were acquired within 15 min of sample preparation (the time for shimming and acquisition), NAA degradation to acetate occurred during the acquisition. As NAA was highlighted as one of the perturbed metabolites in the PC analysis of cerebral tissue extracts, the degradation rate of NAA and the rate of formation of acetate was measured by sequentially acquiring spectra every 30 min (each spectrum required a 5-min acquisition and a 25-min delay prior to the next acquisition), to test the hypothesis that NAA degradation was slower in mnd mice (Fig. 6B) . Measuring both the direct rate and the rate of accumulation of acetate, degradation of NAA was slower in tissue from mnd mice compared with that from control animals (mnd, NAA ϭ Ϫ0.0018 Ϯ 0.0002/min; control, NAA ϭ Ϫ0.0022 Ϯ 0.0001/min; P ϭ 0.0059 for Student's t-test). (Note: boldface indicates "resonance observed.") Peak 1, CH3CH2 low-density lipids (LDL); peak 2, CH3CH2 very low-density lipids (VLDL); peak 3, isoleucine; peak 4, leucine; peak 5, valine; peak 6, ethanol; peak 7, CH2CH2CH2 VLDL and LDL; peak 8, lactate; peak 9, alanine; peak 10, COCH2CH2; peak 11, lysine ϩ arginine; peak 12, acetate; peak 13, OCH2OCACO; peak 14, N-acetyl glycoproteins; peak 15, N-acetyl glycoproteins; peak 16, OCH2CO lipids; peak 17, EDTA; peak 18, calcium EDTA 2Ϫ ; peak 19, magnesium EDTA 2Ϫ ; peak 20, OCACOCH2OCAC lipids; peak 21, albumen lysyl groups; peak 22, choline; peak 23, C2H ␤-glucose; peak 24, glycerol. B: comparison between spectra obtained from mnd and control mouse sera to demonstrate the reduction in glucose-containing resonances in the plasma from mnd mice. C: principal component analysis (PCA) of sera spectra from the two mouse strains and three diets. Plasma from mnd mice had a distinct metabolic profile compared with control animals regardless of diet. Numbers indicate diet; s, control spectra; E, mnd mice. D: loadings plot to show metabolites that contribute most to this separation. Metabolites found in the top right are increased and those in the bottom left are decreased in spectra of mnd mouse sera.
DISCUSSION
Vitamin E is decreased in mnd tissue. Free radical damage is implicated in the different forms of NCL as well as other neurodegenerative diseases, including Parkinson's disease and ALS. Highly reactive OH radicals oxidize unsaturated fatty acids within cell membranes, forming lipid hydroperoxides and disrupting cell membrane integrity and fluidity. The high redox reactivity, coupled with cell membranes rich in polyunsaturated fatty lipids, predispose neuronal tissues, especially motor neurons, to free radical damage. It has been suggested that dietary supplementation with antioxidants may reverse the pathologies of these diseases (3, 17, 33) .
The concentration of vitamin E is reduced in cerebral tissue and blood plasma from mnd mice, and features of primary vitamin E deficiency include a number of neurological symptoms, such as ataxia, loss of proprioception and deep tendon reflexes, and retinal damage (22) . However, the concentration of vitamin E in mnd mice fed on a non-supplemented diet was greater than those reported in deficiency disorders. Furthermore, the deficit in vitamin E concentration was reversed by dietary supplementation, but this did not prevent the progression of cerebral disorders in mnd mice. Histology confirmed that cerebral tissue had characteristic lesions, similar to those found in human patients of NCL (30) , in all groups of mnd mice studied, with no differences in the quantity or distribution of inclusion material regardless of diet. In the present study we have used 1 H-NMR spectroscopy of cerebral tissue extracts and intact tissue to directly study which metabolic abnormalities could and could not be corrected by vitamin E supplementation, by defining a metabolic phenotype for each treatment group.
Metabolic profiles of mnd mice are distinct from control mice. The decreased sera concentrations of glucose and lactate accompanied by an increase in the ratio of CH 2 CH 2 CH 2 /CH 2 CH 3 lipid moieties indicate a perturbation between carbohydrate and lipid metabolism, further supported by the large concentration of ␤-hydroxybutyrate detected in cerebral tissue, a known consequence of prolonged starvation and non-insulindependent diabetes (25) . However, the concentration of ␤-hydroxybutyrate present within blood sera was small for both groups (unlike during starvation; 25), typically obscured by other resonances, and no differences in animal weights or food intake between groups were noted. Instead these changes are characteristic of a profound metabolic disorder in terms of glucose management, such as occurs during non-insulin-dependent diabetes.
Striking differences were detectable in spectra from intact tissue, with mnd mice possessing a high concentration of CH 2 CH 2 CH 2 lipid moieties, just as detected in sera. The spectral profiles from mnd tissue also had a pronounced resonance associated with CHACH lipid moieties, primary sites of free radical attack, as well as being associated with apoptosis in tumors of the brain (14) . Thus the lipid profile of cortical tissue from mnd mice demonstrates characterizable metabolic deficits consistent with an abnormality in lipid metabolism, such as caused by faulty production of MAMs, as suggested by Vance and coworkers (34) . Impaired formation of MAMs is thought to cause a redistribution of MAMassociated enzymes, including a number involved in lipid metabolism, such as phosphatidylethanolamine N-methyltransferase-2, CTP:phosphocholine cytidyltransferase, and phosphatidylserine synthase. Defective membrane formation has also been implicated in juvenile NCL, both in terms of total phosphatidylcholine, phosphatidylserine, and phosphatidylethanolamine in erythrocytes and platelets, and impaired Ca 2ϩ mobilization in fibroblasts (2, 3). Peroxide damage then arises because of reduced transport of lipids between the endoplasmic reticulum and the mitochondria. Disruptions in lipid metabolism, particularly events associated with lysosomes, appear common to all the NCL-related disorders (3, 10, 16, (35) (36) .
The low-molecular-weight metabolites also provided a unique insight into the disease process. Phenylala- Fig. 4 . A: 600.13 MHz high-resolution 1 H-NMR spectrum of a perchloric acid extract of cortex tissue from the mnd mouse. Peak 1, valine, leucine, isoleucine; peak 2, ␤-hydroxybutyrate; peak 3, lactate; peak 4, alanine; peak 5, ␥-aminobutyric acid (GABA); peak 6, N-acetyl-L-aspartate (NAA); peak 7, glutamate and glutamine; peak 8, glutamate; peak 9, succinate; peak 10, glutamine; peak 11, hypotaurine and aspartate; peak 12, aspartate; peak 13, creatine; peak 14, choline; peak 15, phosphocholine; peak 16, taurine; peak 17, myoinositol (and smaller contributions from glycine, ␣ protons of amino acids and glucose); and peak 18, phenylalanine. B and C: enlargements of 1 H spectra from mnd mice on diets 1 and 2 showing main differences between spectral profiles. nine was detected in cerebral tissue of mnd mice, with a host of neurological pathologies, including phenylketouria, characterized by impaired metabolism of phenylalanine and hence a failure to maintain tyrosine and dopamine concentrations within cerebral tissue (23) . This deficit could be corrected by supplementation with vitamin E. However, regardless of diet, concentrations of lactate, glutamate, and NAA were all increased in mnd cerebral tissue, whereas that of creatine, glutamine, aspartate, and GABA were decreased, and these differences were more pronounced than those induced by dietary supplementation. GABAergic interneurons are selectively lost in mouse models of NCL and infantile NCL (8, 9) explaining the decrease in GABA detected. However, the increase in neuronal markers NAA and glutamate at the expense of creatine and glutamine, glial markers of metabolism, in mnd cerebral tissue is counterintuitive for a disease that primarily affects motor neurons. Vance and colleagues (34) , studying enzyme expression in liver tissue from mnd mice, made the observation that while certain enzymes were decreased in concentration in the MAMs, their expression in the overall tissue was the same as control tissue, suggesting a redistribution of the enzymes. Thus the distribution of metabolites across intracellular compartments may be altered within cerebral tissue from mnd mice.
Tissue removal takes a finite amount of time, particularly where tissue sections are also taken for histology, preventing the use of such techniques as funnel freezing. The slower degradation of NAA in cerebral tissue from mnd mice suggests that the actual concentration of NAA was the same in both mouse strains at the time of death, but differences were caused by different degradation rates. This may be caused by impaired transport of the metabolite from its production in the mitochondria to where it is metabolized, presumably connected to defective MAMs production. This is intriguing, as although the exact metabolic purpose of NAA is still disputed, it has been suggested to be a precursor in myelin production or involved in water homeostasis, with both events involving oligodendrocytes, providing a link between NAA degradation, lipid diet 3 (s) . E: OSC filtered data of all mice fed diet 1 (E) or diet 2 or 3 (s) (see RESULTS for explanation of preprocessing routine). F: contributions plot for the separation of mnd and control mice fed diet 1 (see B for PC loadings). The x-axis represents the different 0.04 ppm integral regions used as metabolic descriptors (arranged to reflect a NMR spectrum), whereas the y-axis measures the importance of the contribution of each metabolite. Key metabolites are labeled, with mnd mice having a negative score in this PC (i.e., decreased creatine, glutamine, etc., but increased glutamate and NAA). G: contributions plot for cerebral tissue of mnd and control mice fed diet 2. 
Key metabolite changes were identified by multiparametric analysis using the automated integral data set or using standard parametric tests following manual integration of resonances; ϩ and Ϫ indicate either an increase or decrease in metabolite concentration in either mnd mice, or induced by diet 2 for columns 2 and 3, respectively. Chemical groups in boldface indicate resonance observed. metabolism/transport, and metabolism within glia (1, 6) . The neurological disorders associated with the disruption of the CLN8 gene appear connected with these metabolic differences, as despite the ability of vitamin E to correct the concentration of phenylalanine within the tissue, there was no effect on observational or histopathological phenotype. Although NAA is decreased in human sufferers of juvenile NCL, presumably this is a result of significant neuronal cell loss in this more progressive form and hence not a primary marker of the disease process.
Vitamin E supplementation did not correct all metabolic abnormalities. Supplementation of the diet with vitamin E reversed the detected deficit in vitamin E in mnd mice, increasing cerebral and blood sera concentrations to above control values. However, none of the resultant metabolic changes were as great as the primary metabolic deficit associated with NCL. With PC analysis of the sera and cortical tissue data sets, spectra from mnd and control mice could always be separated regardless of diet. Indeed, to determine the effects of vitamin E, either a two-group comparison or a data filtration technique such as OSC was necessary (11) . In all cases, vitamin E was not directly detected in the NMR spectra (even in the most oxidative environments, such as the mitochondrial membrane, vitamin E concentration is 1:500 relative to lipids; 4). Hence, all the changes detected arose from the biochemical effects of the vitamin rather than its direct effects on the spectra.
Diet 2 caused a decrease in unsaturated fatty acids circulating in blood in mnd mice but not control mice.
As vitamin E is expected to decrease peroxidation of unsaturated fats, a decrease in circulating polyunsaturated fats in the mnd mice suggests that there is a decrease in turnover of these metabolites in the tissues of the body, caused by decreases in peroxidation of membranes, particularly mitochondrial. Despite this change induced by vitamin E supplementation, lactate and glucose remained decreased in the blood plasma of mnd mice fed diet 2 or 3, and the changes in lipid resonances suggested that sera from mnd mice contained longer chain fatty acids than in control animals (i.e., increased CH 2 CH 2 CH 2 resonance intensities), just as in the mice fed diet 1.
In this study two antioxidant-supplemented diets were used. Vitamin C is water soluble, but it has been suggested that it may be involved in regenerating vitamin E (26), while selenium is a constituent of glutathione peroxidase, which reduces peroxides. However, in both serum and cerebral tissue no metabolic differences were detected between the two diets, with metabolic changes being most pronounced in the vitamin E supplemented diet 2.
Conclusion. With increasing number of genetically modified organisms, it is becoming apparent that new phenotyping techniques are necessary to explore the functional genomics of a given gene deletion or modification. This has led to the emergence of metabolic profiling techniques reliant on NMR spectroscopy or mass spectrometry referred to as "metabonomics" or "metabolomics" (24, 28) . This approach is illustrated in this study by the mnd mouse, whose phenotype is characterized by a reduction in cerebral and sera concentrations of vitamin E, although reversal of this deficit failed to prevent the pathological effects associated with NCL. Deriving metabolic profiles, using a technique such as high-resolution 1 H-NMR spectroscopy, a metabolic phenotype was produced determining the pathways corrected and uncorrected by vitamin E supplementation. Such an approach should be equally applicable to any animal model of disease, providing a rapid and convenient way to predict metabolic phenotypes.
This work is supported by the Motor Neuron Disease Association, the Special Trustees of the Royal London Hospital, The Annie Lindsell Trust, and the Birth Defects Foundation. J. L. Griffin is grateful Fig. 6 . A: 600.13 MHz high-resolution magic angle spinning 1 H-NMR spectra of intact cortical tissue from a mnd and control mouse. Tissue from the mnd mice with resonances at 1.30 ppm (long-chain alkane groups) and 5.35 ppm (unsaturated lipid moieties). Peak 1, CH3CH2 lipid groups; peak 2, CH2CH2CH2 lipid groups; peak 3, lactate; peak 4, acetate; peak 5, NAA; peak 6, creatine; peak 7, choline and phosphocholine; peak 8, phosphatidylcholine; peak 9, glycerol; and peak 10, CHACH lipid groups. B: degradation of NAA to acetate at 300 K in a piece of intact cortical tissue from a control mouse.
